MMTVX Performance — MassMutual Select T. Rowe Price Retirement 2020 Fund, Class M3
Data updated: 2025-08-25
MMTVX returned +8.77% over one year to Jun 2025. Annualised returns are +8.98% over 3 years and +6.73% over 5 years. The fund trailed its Target-Date category average: $100 invested three years ago grew to $129, against $141 for the category, and to $109 over one year, against $112. Volatility over the past three years was 9.59% a year. In the 12 months to Jun 2025 the fund lost a net $343.1M, and assets reached $88.23M.
MMTVX Growth of $100
What $100 invested in MassMutual Select T. Rowe Price Retirement 2020 Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Target-Date category average over the same months.
| Period | MMTVX | Category average |
|---|---|---|
| 1 year (Jul 2024 – Jun 2025) | $109 | $112 |
| 3 years (Jul 2022 – Jun 2025) | $129 | $141 |
| 5 years (Jul 2020 – Jun 2025) | $138 | $154 |
| Since data start (Jul 2019 – Jun 2025) | $143 | $159 |
MMTVX Trailing Returns
Total returns to Jun 2025, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | +8.77% |
| 3 years (annualised) | +8.98% |
| 5 years (annualised) | +6.73% |
MMTVX Annual Returns
Calendar-year total returns of MassMutual Select T. Rowe Price Retirement 2020 Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2025 (Jan–Jun) | +5.51% |
| 2024 | +8.60% |
| 2023 | +12.94% |
| 2022 | −15.19% |
| 2021 | +9.72% |
| 2020 | +12.64% |
| 2019 (Jul–Dec) | +5.75% |
MMTVX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | −1.7% | +0.6% | +1.9% | −0.1% | +2.2% | +2.4% | — | — | — | — | — | — |
| 2024 | +2.3% | +2.1% | −0.1% | +0.9% | +2.7% | −2.5% | +1.2% | +1.7% | +1.8% | −2.5% | +2.7% | −1.8% |
| 2023 | +1.9% | −2.1% | +4.7% | +3.0% | −1.1% | +0.9% | −3.0% | −1.6% | +2.0% | +4.1% | +5.7% | −1.8% |
| 2022 | +0.1% | −1.8% | −3.5% | −5.3% | 0.0% | −5.6% | −6.6% | −3.0% | +4.6% | −2.5% | +5.1% | +2.9% |
| 2021 | +1.3% | +1.6% | −0.2% | +0.7% | +0.9% | +2.7% | −2.5% | +1.5% | +0.7% | +1.8% | −1.7% | +2.6% |
| 2020 | −10.7% | −4.0% | −0.1% | +2.3% | +3.6% | +7.8% | −1.9% | +3.1% | +3.7% | +2.9% | +7.4% | −0.8% |
| 2019 | — | — | — | — | — | — | +0.7% | −0.4% | +0.3% | +2.2% | +1.6% | +1.3% |
MMTVX Risk
Risk measures from monthly returns over Jul 2022 – Jun 2025.
- 3-year volatility (annualised): 9.59%
- 3-year Sharpe ratio: 0.47 (vs 4.5% risk-free rate)
- Best month: +5.73% (Nov 2023)
- Worst month: −6.60% (Jul 2022)
MMTVX Fund Flows
Monthly money in and out of MassMutual Select T. Rowe Price Retirement 2020 Fund, from SEC Form N-PORT.
- 12-month net flow: −$343.1M
- 12-month gross sales (incl. reinvestments): $35.1M
- Sales ÷ redemptions: 0.09×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2025 | $392K | $4.8M | −$4.4M |
| May 2025 | $611K | $12.6M | −$12.0M |
| Apr 2025 | $841K | $5.8M | −$4.9M |
| Mar 2025 | $1.6M | $214.2M | −$212.6M |
| Feb 2025 | $1.3M | $6.5M | −$5.2M |
| Jan 2025 | $627K | $9.0M | −$8.4M |
| Dec 2024 | $1.6M | $12.2M | −$10.6M |
| Nov 2024 | $2.5M | $15.6M | −$13.1M |
| Oct 2024 | $15.3M | $8.4M | $6.8M |
| Sep 2024 | $3.8M | $41.8M | −$38.0M |
| Aug 2024 | $4.2M | $34.1M | −$29.9M |
| Jul 2024 | $2.3M | $13.2M | −$11.0M |
MMTVX Assets Under Management
Net assets of MassMutual Select T. Rowe Price Retirement 2020 Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2025-06-30 | $88.23M |
| 2025-03-31 | $104.81M |
| 2024-12-31 | $327.84M |
| 2024-09-30 | $362.62M |
| 2024-06-30 | $422.41M |
| 2024-03-31 | $501.21M |
| 2023-12-31 | $495.13M |
| 2023-09-30 | $490.65M |
| 2023-06-30 | $522.49M |
| 2023-03-31 | $525.77M |
| 2022-12-31 | $521.29M |
| 2022-09-30 | $511.86M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.